GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (LTS:0R2S) » Definitions » EV-to-EBITDA

Stryker (LTS:0R2S) EV-to-EBITDA : 28.46 (As of Dec. 13, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Stryker EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Stryker's enterprise value is $154,198 Mil. Stryker's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was $5,419 Mil. Therefore, Stryker's EV-to-EBITDA for today is 28.46.

The historical rank and industry rank for Stryker's EV-to-EBITDA or its related term are showing as below:

LTS:0R2S' s EV-to-EBITDA Range Over the Past 10 Years
Min: 12.66   Med: 24.19   Max: 37.99
Current: 28.46

During the past 13 years, the highest EV-to-EBITDA of Stryker was 37.99. The lowest was 12.66. And the median was 24.19.

LTS:0R2S's EV-to-EBITDA is ranked worse than
72.44% of 479 companies
in the Medical Devices & Instruments industry
Industry Median: 16.05 vs LTS:0R2S: 28.46

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-12-13), Stryker's stock price is $376.0601. Stryker's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $9.330. Therefore, Stryker's PE Ratio (TTM) for today is 40.31.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Stryker EV-to-EBITDA Historical Data

The historical data trend for Stryker's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stryker EV-to-EBITDA Chart

Stryker Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.16 33.79 30.03 25.67 25.08

Stryker Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.57 25.08 28.37 26.61 27.41

Competitive Comparison of Stryker's EV-to-EBITDA

For the Medical Devices subindustry, Stryker's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stryker's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stryker's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Stryker's EV-to-EBITDA falls into.



Stryker EV-to-EBITDA Calculation

Stryker's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=154198.125/5419
=28.46

Stryker's current Enterprise Value is $154,198 Mil.
Stryker's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $5,419 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stryker  (LTS:0R2S) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Stryker's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=376.0601/9.330
=40.31

Stryker's share price for today is $376.0601.
Stryker's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.330.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Stryker EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Stryker's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Stryker Business Description

Address
1941 Stryker Way, Portage, MI, USA, 49002
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.

Stryker Headlines

No Headlines